Shangya Technology Co., Ltd. (TPEX:6130)
24.65
-1.70 (-6.45%)
Sep 8, 2026, 1:30 PM CST
Shangya Technology Market Cap
Shangya Technology has a market cap or net worth of 1.14 billion as of September 8, 2026. Its market cap has decreased by -37.24% in one year.
Market Cap
1.14B
Enterprise Value
1.17B
Revenue
165.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.65
ChartMarket Cap Chart
Since November 3, 2004, Shangya Technology's market cap has increased from 885.72M to 1.14B, an increase of 28.85%. That is a compound annual growth rate of 1.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.14B | -42.11% |
| Dec 31, 2025 | 1.97B | 88.96% |
| Dec 31, 2024 | 1.04B | -31.54% |
| Dec 29, 2023 | 1.52B | 15.05% |
| Dec 30, 2022 | 1.32B | -7.53% |
| Dec 30, 2021 | 1.43B | 117.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 542.91B |
| Caliway Biopharmaceuticals | 134.39B |
| Lin BioScience | 120.65B |
| Pell Bio-Med Technology | 97.62B |
| Arich Enterprise | 1.28B |
| GeneFerm Biotechnology | 1.25B |
| Abnova (Taiwan) | 1.24B |
| NeoCore Technology | 1.23B |